wift Biosciences develops enabling technologies for genomics, translational, and clinical research applications. Our technologies push the limits and extend the applications of next-generation sequencing (NGS) and polymerase chain reaction (PCR). We have developed unique intellectual property (IP) in the fields of ligation, amplification, purification, and DNA repair.
Using our IP technology, Swift has developed DNA sequencing library kits for use with double-stranded DNA, single-stranded DNA, and bisulfite-converted DNA. These kits enable the construction of libraries from difficult-to-use and preciously limiting samples, such as FFPE and cfDNA. Our technology is platform agnostic and applicable across the three major NGS platforms: Illumina, Ion Torrent, and Pacific Biosciences.
We have developed unique methods that allow the construction of targeted DNA sequencing libraries in a single tube, from minute amounts of DNA in less than 2 hours. Our amplification technology enables the design of overlapping amplicons and offers full gene coverage. Our amplification technology has been developed for use with fragmented DNA isolated from samples, such as FFPE and cfDNA.
Swift Biosciences offers a suite of differentiated products and technologies for use in next-generation sequencing (NGS) sample preparation. These technologies are based on proprietary IP, applications, methods, protocols, and reagents invented by Swift Biosciences.
Our product and technology portfolio share the features of being fast, easy, and compatible with existing NGS instrumentation.